首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy
【24h】

Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy

机译:谷胱甘肽(GSH)的慢性耗竭和体内LDL的最低程度的改变:谷胱甘肽单酯(GME)治疗的预防

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A decline in reduced glutathione (GSH) level is associated with aging and free radical mediated diseases. The objective of this study was to determine whether the chronic depletion of extra cellular GSH causes oxidative damage to the circulating macromolecules such as lipoproteins. Decreased concentrations of plasma glutathione, vitamin E and ascorbic acid were recorded in the rats treated with buthionine sulfoximine (BSO), a selective GSH inhibitor. In LDL isolated from BSO-treated animals, the concentration of malondialdehyde (MDA) and conjugated dienes were significantly increased (P < 0.01), whereas the levels of vitamin E were decreased (P < 0.01). The analysis of total and LDL cholesterol revealed significant changes between the control and experimental groups. Of interest, altered concentrations of lysophosphatidyl choline (Lyso-PC) and phosphatidyl choline (PC) were recorded from the BSO mediated minimally modified LDL. A negative correlation between LDL-BDC/MDA and its antioxidant capacity was noted. Upon in vitro oxidation with CuSO4, the electrophoretic behavior of purified LDL-apoprotein-B on agarose gel showed an increased mobility in BSO-treated rats, indicative of in vivo modification of LDL to become susceptible for in vitro oxidation. The increased mobility of LDL (after in vitro oxidation) isolated from the BSO-treated animals correlates with a decrease in its amino groups, as determined by the trinitrobenzene sulfonic acid (TNBS) reactants. However, the mobility of LDL molecule was not altered due to BSO treatment in vivo. Interestingly, the minimal modification on LDL does not lead to any vascular damage in the dorsal aorta of the rats injected with BSO. The administration of glutathione monoester (GME), at a dose of 5 mmol/kg body weight, twice a day, for 30 days, to animals treated with L-buthionine-SR-sulfoximine (BSO, 4 mmol/kg body weight, twice a day, for 30 days) normalized the antioxidant status and prevented the minimal modifications on LDL. Thus, increasing the cellular GSH levels may trigger beneficial effects against oxidative stress. (c) 2004 Elsevier B.V. All rights reserved.
机译:谷胱甘肽(GSH)含量降低与衰老和自由基介导的疾病有关。这项研究的目的是确定细胞外GSH的长期消耗是否引起循环大分子(如脂蛋白)的氧化损伤。在用丁硫氨酸亚砜亚胺(BSO)(一种选择性的GSH抑制剂)治疗的大鼠中,血浆谷胱甘肽,维生素E和抗坏血酸的浓度降低。从经BSO处理的动物中分离出的LDL中,丙二醛(MDA)和共轭二烯的浓度显着增加(P <0.01),而维生素E的水平降低(P <0.01)。对总胆固醇和LDL胆固醇的分析显示,对照组和实验组之间存在显着变化。有趣的是,从BSO介导的最小修饰LDL记录了溶血磷脂酰胆碱(Lyso-PC)和磷脂酰胆碱(PC)的浓度变化。注意到LDL-BDC / MDA与其抗氧化能力之间呈负相关。在用CuSO4体外氧化后,纯化的LDL-载脂蛋白B在琼脂糖凝胶上的电泳行为在BSO处理的大鼠中显示出增加的迁移率,表明体内对LDL的修饰使其易于在体外氧化。从BSO处理过的动物中分离出的LDL(在体外氧化后)增加的迁移率与其氨基的减少相关,如三硝基苯磺酸(TNBS)反应物所确定的。然而,由于体内的BSO治疗,LDL分子的迁移率没有改变。有趣的是,对LDL的最小修饰不会在注射BSO的大鼠的背主动脉中引起任何血管损伤。每天两次,以5 mmol / kg体重的剂量向每天用L-buthionine-SR-亚磺酰亚胺(BSO,4 mmol / kg体重,两次的动物)给予谷胱甘肽单酯(GME)每天,持续30天)使抗氧化剂状态恢复正常,并阻止了LDL的最小修饰。因此,增加细胞中GSH的水平可能会触发抗氧化应激的有益作用。 (c)2004 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号